QuartzBio’s approach to biomarker data management can be seen in the context of a phase 2/3 dose evaluation and expansion oncology study with 5 assays run at 4 different labs. Using QuartzBio’s technology-driven solution, the sponsor could:
- Pull together and visualize PK, cytokine, and flow cytometry data to inform optimal dosing
- Integrate mutation, IHC, and cytokine data to develop a multimarker signature to stratify patients
The cross-functional QuartzBio team—including data scientists, biomarker data management programmers, and data managers—delivered a centralized data hub for biomarker data transfer, integration, and collaboration, as well as interactive reports and support for ongoing trial activities.
The client found that our approach transformed their ability to reach key clinical trial objectives.